Paper28975475
Pharmacogenomics of Bucindolol in Atrial Fibrillation and Heart Failure.
Parikh KS and 1 other. Curr Heart Fail Rep, 2017. Cited by 2 papers, by iCite.
Cite this record
ConductScience Library. Pharmacogenomics of Bucindolol in Atrial Fibrillation and Heart Failure. Papers, record 28975475. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/28975475
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics9
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Atrial Fibrillation | Major topic |
| Heart Failure | Major topic |
| Pharmacogenetics | Major topic |
| Propanolamines | Major topic |
| Receptors, Adrenergic, beta-1 | Major topic |
| Stroke Volume | Major topic |
| Adrenergic beta-Antagonists | |
| Genotype | |
| Humans |
Source PubMed
References36
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 24332148 | Genetic variation in the β1-adrenergic receptor is associated with the risk of atrial fibrillation after cardiac surgery. | Am Heart J | 2014 | https://conductscience.org/library/papers/24332148 | PubMed |
| 2 | 25125304 | Rhythm control in heart failure patients with atrial fibrillation: contemporary challenges including the role of ablation. | J Am Coll Cardiol | 2014 | https://conductscience.org/library/papers/25125304 | PubMed |
| 3 | 11386264 | A trial of the beta-blocker bucindolol in patients with advanced chronic heart failure. | N Engl J Med | 2001 | https://conductscience.org/library/papers/11386264 | PubMed |
| 4 | 11333992 | Race and the response to adrenergic blockade with carvedilol in patients with chronic heart failure. | N Engl J Med | 2001 | https://conductscience.org/library/papers/11333992 | PubMed |
| 5 | 24088125 | β1- and α2C-adrenergic receptor polymorphisms and the antiarrhythmic effect of bucindolol in heart failure with reduced ejection fraction. | Pharmacogenomics | 2013 | https://conductscience.org/library/papers/24088125 | PubMed |
| 6 | 24159564 | Prevention of atrial fibrillation by bucindolol is dependent on the beta₁389 Arg/Gly adrenergic receptor polymorphism. | JACC Heart Fail | 2013 | https://conductscience.org/library/papers/24159564 | PubMed |
| 7 | 27560277 | Rate control in atrial fibrillation. | Lancet | 2016 | https://conductscience.org/library/papers/27560277 | PubMed |
| 8 | 22617224 | Impact of the β1-adrenoceptor Arg389Gly polymorphism on heart-rate responses to bisoprolol and carvedilol in heart-failure patients. | Clin Pharmacol Ther | 2012 | https://conductscience.org/library/papers/22617224 | PubMed |
| 9 | 28089316 | Decreased Mortality With Beta-Blockers in Patients With Heart Failure and Coexisting Atrial Fibrillation: An AF-CHF Substudy. | JACC Heart Fail | 2017 | https://conductscience.org/library/papers/28089316 | PubMed |
| 10 | 12374873 | Synergistic polymorphisms of beta1- and alpha2C-adrenergic receptors and the risk of congestive heart failure. | N Engl J Med | 2002 | https://conductscience.org/library/papers/12374873 | PubMed |
| 11 | 25193873 | Efficacy of β blockers in patients with heart failure plus atrial fibrillation: an individual-patient data meta-analysis. | Lancet | 2014 | https://conductscience.org/library/papers/25193873 | PubMed |
| 12 | 25443111 | Race, common genetic variation, and therapeutic response disparities in heart failure. | JACC Heart Fail | 2014 | https://conductscience.org/library/papers/25443111 | PubMed |
| 13 | 22260944 | Association of β-blocker exposure with outcomes in heart failure differs between African American and white patients. | Circ Heart Fail | 2012 | https://conductscience.org/library/papers/22260944 | PubMed |
| 14 | 15767288 | Prognostic relevance of atrial fibrillation in patients with chronic heart failure on long-term treatment with beta-blockers: results from COMET. | Eur Heart J | 2005 | https://conductscience.org/library/papers/15767288 | PubMed |
| 15 | 19880803 | An alpha2C-adrenergic receptor polymorphism alters the norepinephrine-lowering effects and therapeutic response of the beta-blocker bucindolol in chronic heart failure. | Circ Heart Fail | 2010 | https://conductscience.org/library/papers/19880803 | PubMed |
| 16 | 16697316 | Atrial fibrillation and risk of clinical events in chronic heart failure with and without left ventricular systolic dysfunction: results from the Candesartan in Heart failure-Assessment of Reduction in Mortality and morbidity (CHARM) program. | J Am Coll Cardiol | 2006 | https://conductscience.org/library/papers/16697316 | PubMed |
| 17 | 25217435 | Potential applications of pharmacogenomics to heart failure therapies. | Heart Fail Clin | 2014 | https://conductscience.org/library/papers/25217435 | PubMed |
| 18 | 25959096 | Bucindolol hydrochloride in atrial fibrillation and concomitant heart failure. | Expert Rev Cardiovasc Ther | 2015 | https://conductscience.org/library/papers/25959096 | PubMed |
| 19 | 1973638 | Effect of beta-adrenergic blockade on myocardial function and energetics in congestive heart failure. Improvements in hemodynamic, contractile, and diastolic performance with bucindolol. | Circulation | 1990 | https://conductscience.org/library/papers/1973638 | PubMed |
| 20 | 10662755 | beta-adrenergic receptor blockade in chronic heart failure. | Circulation | 2000 | https://conductscience.org/library/papers/10662755 | PubMed |
Cited by2
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 2 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 41372115 | The beta1-adrenergic receptor in the heart. | Cell Death Discov | 2025 | https://conductscience.org/library/papers/41372115 | PubMed |
| 35440173 | Premarket assessment of molecular alterations in drug targets: a case study of 2020 drug approvals. | Pharmacogenomics | 2022 | https://conductscience.org/library/papers/35440173 | PubMed |
Genes1
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes |
|---|---|---|---|
| ADRB1 | 153 | PubTator's text mining | https://conductscience.org/library/genes/153 |
Source NCBI Gene
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/28975475
GET https://conductscience.org/api/papers/v1/28975475/references?page=2